| Literature DB >> 35300076 |
Sopida Thavornpradit1, Syed Muhammad Usama1, G Kate Park2, Jason Dinh2, Hak Soo Choi2, Kevin Burgess1.
Abstract
MHI-I2 (1) and QuatCy-I2 (2) were compared in terms of properties important for early-stage photodynamic therapy preclinical candidates. Thus, experiments were performed to monitor dark cytotoxicities, light/dark cytotoxicity ratios, selectivity of localization in tumors over other organs, and clearance from the plasma.Entities:
Year: 2022 PMID: 35300076 PMCID: PMC8919274 DOI: 10.1021/acsmedchemlett.1c00640
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345